Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

Low-Dose 0.01% Atropine Eye Drops vs Placebo ...

Up next

Diabetes Severity in Cornea Donors and 1-Year Outcomes in Recipients

Interview with Jonathan H. Lass, MD, author of Diabetes Severity in Cornea Donors and 1-Year Outcomes in Recipients in the Diabetes Endothelial Keratoplasty Study: A Secondary Analysis of a Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Diabetes Severity ...  Show more

Why Metrics Matter in Thyroid Eye Disease

Interview with Michael Kazim, MD, author of Why Metrics Matter in Thyroid Eye Disease: An Innovate TED Initiative. Hosted by Neil Bressler, MD. Related Content: Why Metrics Matter in Thyroid Eye Disease 

Recommended Episodes

Eye to Eye Ophthalmology: The past, present and future of myopia management
Eye to Eye: An Ophthalmology Podcast from the Royal College of Ophthalmologists

In this episode with speak with Bhavin Shah, an Optometrist from North London with a special interest in myopia management. He provides an overview of the literature regarding existing and future treatments and provides a personal insight into how he manages patients in whom p ...

  Show more

Eye to Eye Ophthalmology: How to reduce the risk of endophthalmitis in patients attending for intravitreal injections
Eye to Eye: An Ophthalmology Podcast from the Royal College of Ophthalmologists

In this episode we speak with Quresh Mohamed, a Consultant Ophthalmologist from Cheltenham. We discuss his paper entitled, 'Post-injection endophthalmitis rates with reduced povidone-iodine prophylaxis in patients with self-reported iodine sensitivity'.


 

Choroidal Changes after Red Light Therapy
Ophthalmology Journal

Please tell us what you think of our show in a brief 2-minute survey: https://forms.office.com/r/B4rYtvpQad

Red Light Therapy has emerged as a new treatment for myopia control. Dr. ...

  Show more